This company is developing a new class of oligonucleotide therapeutics based on its proprietary platform technology.
Business Model:
Revenue: $0
Employees: 11-50
Address: 665 India Street Suite 204
City: San Diego
State: CA
Zip: 92101
Country: US
We are an US-German biotechnology company located in San Diego and Bochum developing novel oligonucleotide therapeutics based on our platform technology for systemic delivery. Our compounds are highly active in virtually all organs, including tumors and metastases, therefore we focus on oncology.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2011 | Seed Round | 1 | - |
Mey Capital Matrix Mey Capital Matrix |
2/2011 | Seed Round | 1 | - |
Mey Capital Matrix Mey Capital Matrix |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|